Search
for

    GlossaryWnt antagonist

    substance that blocks Wnt signaling, affecting cell growth

    A Wnt antagonist is a substance that inhibits the Wnt signaling pathway, which is crucial for various biological processes including cell growth, development, and hair follicle formation. By blocking this pathway, Wnt antagonists can affect hair growth and are being studied for their potential in treating conditions like alopecia.

    Related Terms

    Learn

    4 / 4 results

      learn Follistatin

      glycoprotein that inhibits TGF-β and promotes hair growth by antagonizing activin

      learn KY19382

      compound that activates Wnt/β-catenin to promote hair regrowth and create new hair follicles

      learn Estradiol

      an estrogen promoting hair regrowth more commonly used in women

    Research

    5 / 1000+ results

    Community Join

    5 / 63 results

      community A concise, easy-to-understand post on Androgenic Alopecia theory and its practical applications

      in Research/Science  92 upvotes 2 years ago
      The mechanism of Androgenic Alopecia and practical applications of treatments like Minoxidil, Finasteride, RU58841, dermarolling, scalp massages, anti-fungals, progesterone, estrogen, PPAR-γ activators, reducing oxidative stress, and scalp exercises. It explains why DHT is important in AA and how other factors might be involved such as hypoxia, increased DKK-1 expression, morphological changes to the scalp, skull growth during childhood/puberty, and blood flow.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 2 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community What to look Forward to in 2025

      in Research/Science  17 upvotes 3 weeks ago
      Hair loss treatments are advancing, with Coegin Pharma's FOL005 expected this year and Breezula potentially later. Pyrilutamide is available but not very effective, while Kintor's products face skepticism; traditional treatments like finasteride and minoxidil remain dominant.